Ørsted Valuation
Is ORSTEC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ORSTEC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ORSTEC (DKK440.4) is trading above our estimate of fair value (DKK121.41)
Significantly Below Fair Value: ORSTEC is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ORSTEC?
Other financial metrics that can be useful for relative valuation.
| What is ORSTEC's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | DKK 182.21b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.2x |
| Enterprise Value/EBITDA | 8.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ORSTEC's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.3x | ||
DRX Drax Group | 0.3x | -6.2% | UK£2.4b |
SSE SSE | 1.9x | 2.3% | UK£20.1b |
UU. United Utilities Group | 3.7x | 8.1% | UK£7.2b |
SVT Severn Trent | 3.4x | 6.3% | UK£7.9b |
ORSTEC Ørsted | 2.5x | 8.2% | DKK 182.2b |
Price-To-Sales vs Peers: ORSTEC is expensive based on its Price-To-Sales Ratio (2.5x) compared to the peer average (2.3x).
Price to Earnings Ratio vs Industry
How does ORSTEC's PE Ratio compare vs other companies in the European Renewable Energy Industry?
Price-To-Sales vs Industry: ORSTEC is good value based on its Price-To-Sales Ratio (2.5x) compared to the European Renewable Energy industry average (2.9x).
Price to Sales Ratio vs Fair Ratio
What is ORSTEC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 2.5x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate ORSTEC's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | DKK 440.40 | DKK 472.39 +7.3% | 10.2% | DKK 540.00 | DKK 385.00 | n/a | 23 |
| Oct ’25 | DKK 445.40 | DKK 464.42 +4.3% | 9.3% | DKK 540.00 | DKK 385.00 | n/a | 24 |
| Sep ’25 | DKK 394.05 | DKK 453.88 +15.2% | 11.5% | DKK 550.00 | DKK 360.00 | n/a | 24 |
| Aug ’25 | DKK 409.90 | DKK 456.33 +11.3% | 11.6% | DKK 550.00 | DKK 360.00 | n/a | 24 |
| Jul ’25 | DKK 375.90 | DKK 456.75 +21.5% | 11.8% | DKK 560.00 | DKK 360.00 | n/a | 24 |
| Jun ’25 | DKK 415.80 | DKK 454.63 +9.3% | 12.0% | DKK 560.00 | DKK 360.00 | n/a | 24 |
| May ’25 | n/a | DKK 453.17 0% | 11.9% | DKK 560.00 | DKK 360.00 | n/a | 24 |
| Apr ’25 | DKK 385.65 | DKK 441.78 +14.6% | 13.0% | DKK 560.00 | DKK 340.00 | n/a | 25 |
| Mar ’25 | DKK 377.85 | DKK 440.18 +16.5% | 13.6% | DKK 560.00 | DKK 340.00 | n/a | 25 |
| Feb ’25 | n/a | DKK 432.17 0% | 15.0% | DKK 600.00 | DKK 305.00 | n/a | 24 |
| Jan ’25 | n/a | DKK 413.96 0% | 18.3% | DKK 600.00 | DKK 303.00 | n/a | 24 |
| Dec ’24 | n/a | DKK 414.57 0% | 18.5% | DKK 600.00 | DKK 303.00 | n/a | 23 |
| Nov ’24 | n/a | DKK 541.67 0% | 19.3% | DKK 825.00 | DKK 360.00 | n/a | 24 |
| Oct ’24 | n/a | DKK 573.54 0% | 18.1% | DKK 825.00 | DKK 417.00 | DKK 445.40 | 24 |
| Sep ’24 | n/a | DKK 649.20 0% | 18.6% | DKK 975.00 | DKK 417.00 | DKK 394.05 | 25 |
| Aug ’24 | n/a | DKK 735.42 0% | 13.5% | DKK 975.00 | DKK 474.00 | DKK 409.90 | 26 |
| Jul ’24 | n/a | DKK 733.64 0% | 15.0% | DKK 975.00 | DKK 474.00 | DKK 375.90 | 25 |
| Jun ’24 | n/a | DKK 731.08 0% | 15.6% | DKK 975.00 | DKK 474.00 | DKK 415.80 | 24 |
| May ’24 | n/a | DKK 732.04 0% | 15.6% | DKK 975.00 | DKK 474.00 | n/a | 24 |
| Apr ’24 | n/a | DKK 736.46 0% | 16.1% | DKK 975.00 | DKK 470.00 | DKK 385.65 | 24 |
| Mar ’24 | n/a | DKK 756.72 0% | 13.1% | DKK 975.00 | DKK 525.00 | DKK 377.85 | 24 |
| Feb ’24 | n/a | DKK 767.13 0% | 14.9% | DKK 1,030.00 | DKK 505.00 | n/a | 24 |
| Jan ’24 | n/a | DKK 782.43 0% | 14.8% | DKK 1,030.00 | DKK 505.00 | n/a | 24 |
| Dec ’23 | n/a | DKK 790.76 0% | 15.7% | DKK 1,030.00 | DKK 505.00 | n/a | 24 |
| Nov ’23 | n/a | DKK 830.84 0% | 17.6% | DKK 1,050.00 | DKK 500.00 | n/a | 24 |
| Oct ’23 | n/a | DKK 877.75 0% | 13.4% | DKK 1,050.00 | DKK 610.00 | n/a | 23 |
Analyst Forecast: Target price is less than 20% higher than the current share price.